The Investment Thread
So complete random one here that peaked my interest.
Epizyme. EPZM. They are a commercial stage bio company.
Market cap of 141 million. Total existing shares: 163 million shares.
An insider on Jan 31 2022 bought an additional 22,666,667 shares at a purchase price of 1.50. He now owns 31.8 million shares. Or…19.4% of the entire company. Which I believe is just under the maximum percentage of the company he can own (20%).
Worth noting that of the 163 million shares in existence…..56 million of them were offered at $1.50 on the date of that insider purchase. So they diluted the price with a share offering. He bought 23 million of the 56 million shares that they offered.
So complete random one here that peaked my interest.
Epizyme. EPZM. They are a commercial stage bio company.
Market cap of 141 million. Total existing shares: 163 million shares.
An insider on Jan 31 2022 bought an additional 22,666,667 shares at a purchase price of 1.50. He now owns 31.8 million shares. Or…19.4% of the entire company. Which I believe is just under the maximum percentage of the company he can own (20%).
Worth noting that of the 163 million shares in existence…..56 million of them were offered at $1.50 on the date of that insider purchase. So they diluted the price with a share offering. He bought 23 million of the 56 million shares that they offered.